| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.5 |